January 21, 2021Expert Opinion on Therapeutic Patents123 citationsOpen Access

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

Intervention

Targeting SARS-CoV-2 RNA-dependent RNA polymerase

Targeting SARS-CoV-2 RNA-dependent RNA polymerase may provide useful information for drug development or repurposing against COVID-19.

can provide useful information for drug development or drug repurposing to combat SARS-CoV-2 as well as future pandemics.

KI fragen

Bookmark

View Full Paper

Cite This Study

Vicenti et al. (Thu,) studied this question.

KI fragen

Bookmark

View Full Paper